GILEAD SCIENCES, INC. is 11.4x more valuable than EXELIXIS, INC. by market capitalization ($151.05 B vs $13.22 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EXEL | GILD |
|---|---|---|
| Market cap | $13.22 B | $151.05 B |
| US-listed rank | #789 | #99 |
| Revenue (latest FY) | $2.32B | $29.44B |
| Net income (latest FY) | $782.60M | $8.51B |
| Net margin | 33.7% | 28.9% |
| P/E (trailing FY) | 16.9 | 17.7 |
| SEC filings | 2,488 | 981 |
GILEAD SCIENCES, INC. is 11.4x more valuable than EXELIXIS, INC. by market capitalization ($151.05 B vs $13.22 B).
In their latest fiscal years, EXELIXIS, INC. reported $2.32B in revenue while GILEAD SCIENCES, INC. reported $29.44B.
Full pages: EXELIXIS, INC. and GILEAD SCIENCES, INC., or browse the full rankings.